nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Clobetasol propionate—psoriasis	0.294	0.656	CbGbCtD
Anagrelide—CYP1A2—Methoxsalen—psoriasis	0.154	0.344	CbGbCtD
Anagrelide—Malnutrition—Prednisone—psoriasis	0.000222	0.000402	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000222	0.000402	CcSEcCtD
Anagrelide—Hyperhidrosis—Triamcinolone—psoriasis	0.000221	0.000401	CcSEcCtD
Anagrelide—Convulsion—Betamethasone—psoriasis	0.000221	0.0004	CcSEcCtD
Anagrelide—Convulsion—Dexamethasone—psoriasis	0.000221	0.0004	CcSEcCtD
Anagrelide—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00022	0.000399	CcSEcCtD
Anagrelide—Insomnia—Hydrocortisone—psoriasis	0.00022	0.000399	CcSEcCtD
Anagrelide—Hypertension—Betamethasone—psoriasis	0.00022	0.000399	CcSEcCtD
Anagrelide—Hypertension—Dexamethasone—psoriasis	0.00022	0.000399	CcSEcCtD
Anagrelide—Paraesthesia—Hydrocortisone—psoriasis	0.000218	0.000396	CcSEcCtD
Anagrelide—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000218	0.000396	CcSEcCtD
Anagrelide—Urticaria—Cyclosporine—psoriasis	0.000217	0.000394	CcSEcCtD
Anagrelide—Myalgia—Betamethasone—psoriasis	0.000217	0.000393	CcSEcCtD
Anagrelide—Myalgia—Dexamethasone—psoriasis	0.000217	0.000393	CcSEcCtD
Anagrelide—Abdominal pain—Cyclosporine—psoriasis	0.000216	0.000392	CcSEcCtD
Anagrelide—Body temperature increased—Cyclosporine—psoriasis	0.000216	0.000392	CcSEcCtD
Anagrelide—Vomiting—Mycophenolic acid—psoriasis	0.000215	0.00039	CcSEcCtD
Anagrelide—Discomfort—Dexamethasone—psoriasis	0.000214	0.000388	CcSEcCtD
Anagrelide—Discomfort—Betamethasone—psoriasis	0.000214	0.000388	CcSEcCtD
Anagrelide—Dyspepsia—Hydrocortisone—psoriasis	0.000214	0.000388	CcSEcCtD
Anagrelide—Haemoglobin—Methotrexate—psoriasis	0.000214	0.000388	CcSEcCtD
Anagrelide—Rash—Mycophenolic acid—psoriasis	0.000213	0.000387	CcSEcCtD
Anagrelide—Dermatitis—Mycophenolic acid—psoriasis	0.000213	0.000386	CcSEcCtD
Anagrelide—Pain—Prednisolone—psoriasis	0.000213	0.000386	CcSEcCtD
Anagrelide—Haemorrhage—Methotrexate—psoriasis	0.000213	0.000386	CcSEcCtD
Anagrelide—Hepatitis—Methotrexate—psoriasis	0.000213	0.000386	CcSEcCtD
Anagrelide—Urticaria—Mycophenolate mofetil—psoriasis	0.000212	0.000385	CcSEcCtD
Anagrelide—Headache—Mycophenolic acid—psoriasis	0.000212	0.000384	CcSEcCtD
Anagrelide—Decreased appetite—Hydrocortisone—psoriasis	0.000211	0.000383	CcSEcCtD
Anagrelide—Pharyngitis—Methotrexate—psoriasis	0.000211	0.000383	CcSEcCtD
Anagrelide—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000211	0.000383	CcSEcCtD
Anagrelide—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000211	0.000383	CcSEcCtD
Anagrelide—Urinary tract disorder—Methotrexate—psoriasis	0.00021	0.000381	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00021	0.000381	CcSEcCtD
Anagrelide—Fatigue—Hydrocortisone—psoriasis	0.00021	0.00038	CcSEcCtD
Anagrelide—Vision blurred—Prednisone—psoriasis	0.000209	0.000379	CcSEcCtD
Anagrelide—Urethral disorder—Methotrexate—psoriasis	0.000209	0.000378	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000209	0.000378	CcSEcCtD
Anagrelide—Pain—Hydrocortisone—psoriasis	0.000208	0.000377	CcSEcCtD
Anagrelide—Oedema—Betamethasone—psoriasis	0.000208	0.000377	CcSEcCtD
Anagrelide—Oedema—Dexamethasone—psoriasis	0.000208	0.000377	CcSEcCtD
Anagrelide—Insomnia—Triamcinolone—psoriasis	0.000207	0.000376	CcSEcCtD
Anagrelide—Infection—Dexamethasone—psoriasis	0.000206	0.000374	CcSEcCtD
Anagrelide—Infection—Betamethasone—psoriasis	0.000206	0.000374	CcSEcCtD
Anagrelide—Ill-defined disorder—Prednisone—psoriasis	0.000206	0.000373	CcSEcCtD
Anagrelide—Paraesthesia—Triamcinolone—psoriasis	0.000206	0.000373	CcSEcCtD
Anagrelide—Feeling abnormal—Prednisolone—psoriasis	0.000205	0.000372	CcSEcCtD
Anagrelide—Visual impairment—Methotrexate—psoriasis	0.000205	0.000372	CcSEcCtD
Anagrelide—Anaemia—Prednisone—psoriasis	0.000205	0.000372	CcSEcCtD
Anagrelide—Shock—Betamethasone—psoriasis	0.000204	0.000371	CcSEcCtD
Anagrelide—Shock—Dexamethasone—psoriasis	0.000204	0.000371	CcSEcCtD
Anagrelide—Dyspnoea—Triamcinolone—psoriasis	0.000204	0.00037	CcSEcCtD
Anagrelide—Nervous system disorder—Betamethasone—psoriasis	0.000204	0.00037	CcSEcCtD
Anagrelide—Nervous system disorder—Dexamethasone—psoriasis	0.000204	0.00037	CcSEcCtD
Anagrelide—Thrombocytopenia—Dexamethasone—psoriasis	0.000203	0.000369	CcSEcCtD
Anagrelide—Thrombocytopenia—Betamethasone—psoriasis	0.000203	0.000369	CcSEcCtD
Anagrelide—Tachycardia—Dexamethasone—psoriasis	0.000203	0.000368	CcSEcCtD
Anagrelide—Tachycardia—Betamethasone—psoriasis	0.000203	0.000368	CcSEcCtD
Anagrelide—Dyspepsia—Triamcinolone—psoriasis	0.000202	0.000366	CcSEcCtD
Anagrelide—Nausea—Mycophenolic acid—psoriasis	0.000201	0.000364	CcSEcCtD
Anagrelide—Hyperhidrosis—Dexamethasone—psoriasis	0.000201	0.000364	CcSEcCtD
Anagrelide—Hyperhidrosis—Betamethasone—psoriasis	0.000201	0.000364	CcSEcCtD
Anagrelide—Feeling abnormal—Hydrocortisone—psoriasis	0.0002	0.000363	CcSEcCtD
Anagrelide—Malaise—Prednisone—psoriasis	0.0002	0.000363	CcSEcCtD
Anagrelide—Eye disorder—Methotrexate—psoriasis	0.000199	0.000361	CcSEcCtD
Anagrelide—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000199	0.000361	CcSEcCtD
Anagrelide—Syncope—Prednisone—psoriasis	0.000199	0.000361	CcSEcCtD
Anagrelide—Tinnitus—Methotrexate—psoriasis	0.000199	0.00036	CcSEcCtD
Anagrelide—Anorexia—Dexamethasone—psoriasis	0.000198	0.000359	CcSEcCtD
Anagrelide—Anorexia—Betamethasone—psoriasis	0.000198	0.000359	CcSEcCtD
Anagrelide—Urticaria—Prednisolone—psoriasis	0.000198	0.000359	CcSEcCtD
Anagrelide—Cardiac disorder—Methotrexate—psoriasis	0.000198	0.000358	CcSEcCtD
Anagrelide—Fatigue—Triamcinolone—psoriasis	0.000197	0.000358	CcSEcCtD
Anagrelide—Asthenia—Cyclosporine—psoriasis	0.000196	0.000356	CcSEcCtD
Anagrelide—Pain—Triamcinolone—psoriasis	0.000196	0.000355	CcSEcCtD
Anagrelide—Loss of consciousness—Prednisone—psoriasis	0.000195	0.000353	CcSEcCtD
Anagrelide—Hypotension—Betamethasone—psoriasis	0.000194	0.000352	CcSEcCtD
Anagrelide—Hypotension—Dexamethasone—psoriasis	0.000194	0.000352	CcSEcCtD
Anagrelide—Pruritus—Cyclosporine—psoriasis	0.000194	0.000351	CcSEcCtD
Anagrelide—Urticaria—Hydrocortisone—psoriasis	0.000193	0.00035	CcSEcCtD
Anagrelide—Abdominal pain—Hydrocortisone—psoriasis	0.000192	0.000349	CcSEcCtD
Anagrelide—Body temperature increased—Hydrocortisone—psoriasis	0.000192	0.000349	CcSEcCtD
Anagrelide—Convulsion—Prednisone—psoriasis	0.000192	0.000348	CcSEcCtD
Anagrelide—Mediastinal disorder—Methotrexate—psoriasis	0.000192	0.000348	CcSEcCtD
Anagrelide—Asthenia—Mycophenolate mofetil—psoriasis	0.000192	0.000347	CcSEcCtD
Anagrelide—Hypertension—Prednisone—psoriasis	0.000191	0.000347	CcSEcCtD
Anagrelide—Chills—Methotrexate—psoriasis	0.000191	0.000346	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000189	0.000343	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000189	0.000343	CcSEcCtD
Anagrelide—Pruritus—Mycophenolate mofetil—psoriasis	0.000189	0.000342	CcSEcCtD
Anagrelide—Myalgia—Prednisone—psoriasis	0.000189	0.000342	CcSEcCtD
Anagrelide—Arthralgia—Prednisone—psoriasis	0.000189	0.000342	CcSEcCtD
Anagrelide—Feeling abnormal—Triamcinolone—psoriasis	0.000189	0.000342	CcSEcCtD
Anagrelide—Alopecia—Methotrexate—psoriasis	0.000188	0.000341	CcSEcCtD
Anagrelide—Insomnia—Betamethasone—psoriasis	0.000188	0.000341	CcSEcCtD
Anagrelide—Insomnia—Dexamethasone—psoriasis	0.000188	0.000341	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000188	0.00034	CcSEcCtD
Anagrelide—Diarrhoea—Cyclosporine—psoriasis	0.000187	0.00034	CcSEcCtD
Anagrelide—Paraesthesia—Dexamethasone—psoriasis	0.000187	0.000338	CcSEcCtD
Anagrelide—Paraesthesia—Betamethasone—psoriasis	0.000187	0.000338	CcSEcCtD
Anagrelide—Discomfort—Prednisone—psoriasis	0.000187	0.000338	CcSEcCtD
Anagrelide—Malnutrition—Methotrexate—psoriasis	0.000185	0.000336	CcSEcCtD
Anagrelide—Dyspepsia—Dexamethasone—psoriasis	0.000183	0.000332	CcSEcCtD
Anagrelide—Dyspepsia—Betamethasone—psoriasis	0.000183	0.000332	CcSEcCtD
Anagrelide—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000183	0.000331	CcSEcCtD
Anagrelide—Urticaria—Triamcinolone—psoriasis	0.000182	0.00033	CcSEcCtD
Anagrelide—Body temperature increased—Triamcinolone—psoriasis	0.000181	0.000328	CcSEcCtD
Anagrelide—Dizziness—Cyclosporine—psoriasis	0.000181	0.000328	CcSEcCtD
Anagrelide—Oedema—Prednisone—psoriasis	0.000181	0.000328	CcSEcCtD
Anagrelide—Decreased appetite—Dexamethasone—psoriasis	0.000181	0.000328	CcSEcCtD
Anagrelide—Decreased appetite—Betamethasone—psoriasis	0.000181	0.000328	CcSEcCtD
Anagrelide—Infection—Prednisone—psoriasis	0.00018	0.000326	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000179	0.000325	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Betamethasone—psoriasis	0.000179	0.000325	CcSEcCtD
Anagrelide—Back pain—Methotrexate—psoriasis	0.000179	0.000325	CcSEcCtD
Anagrelide—Fatigue—Betamethasone—psoriasis	0.000179	0.000325	CcSEcCtD
Anagrelide—Fatigue—Dexamethasone—psoriasis	0.000179	0.000325	CcSEcCtD
Anagrelide—Shock—Prednisone—psoriasis	0.000178	0.000323	CcSEcCtD
Anagrelide—Pain—Betamethasone—psoriasis	0.000178	0.000322	CcSEcCtD
Anagrelide—Pain—Dexamethasone—psoriasis	0.000178	0.000322	CcSEcCtD
Anagrelide—Nervous system disorder—Prednisone—psoriasis	0.000178	0.000322	CcSEcCtD
Anagrelide—Tachycardia—Prednisone—psoriasis	0.000177	0.00032	CcSEcCtD
Anagrelide—Dizziness—Mycophenolate mofetil—psoriasis	0.000177	0.00032	CcSEcCtD
Anagrelide—Skin disorder—Prednisone—psoriasis	0.000176	0.000319	CcSEcCtD
Anagrelide—Hyperhidrosis—Prednisone—psoriasis	0.000175	0.000317	CcSEcCtD
Anagrelide—Vision blurred—Methotrexate—psoriasis	0.000175	0.000317	CcSEcCtD
Anagrelide—Asthenia—Hydrocortisone—psoriasis	0.000175	0.000316	CcSEcCtD
Anagrelide—Vomiting—Cyclosporine—psoriasis	0.000174	0.000316	CcSEcCtD
Anagrelide—Rash—Cyclosporine—psoriasis	0.000173	0.000313	CcSEcCtD
Anagrelide—Anorexia—Prednisone—psoriasis	0.000173	0.000313	CcSEcCtD
Anagrelide—Dermatitis—Cyclosporine—psoriasis	0.000172	0.000313	CcSEcCtD
Anagrelide—Pruritus—Hydrocortisone—psoriasis	0.000172	0.000312	CcSEcCtD
Anagrelide—Ill-defined disorder—Methotrexate—psoriasis	0.000172	0.000312	CcSEcCtD
Anagrelide—Headache—Cyclosporine—psoriasis	0.000171	0.000311	CcSEcCtD
Anagrelide—Anaemia—Methotrexate—psoriasis	0.000171	0.000311	CcSEcCtD
Anagrelide—Feeling abnormal—Dexamethasone—psoriasis	0.000171	0.00031	CcSEcCtD
Anagrelide—Feeling abnormal—Betamethasone—psoriasis	0.000171	0.00031	CcSEcCtD
Anagrelide—Gastrointestinal pain—Betamethasone—psoriasis	0.00017	0.000308	CcSEcCtD
Anagrelide—Gastrointestinal pain—Dexamethasone—psoriasis	0.00017	0.000308	CcSEcCtD
Anagrelide—Vomiting—Mycophenolate mofetil—psoriasis	0.00017	0.000308	CcSEcCtD
Anagrelide—Rash—Mycophenolate mofetil—psoriasis	0.000168	0.000305	CcSEcCtD
Anagrelide—Dermatitis—Mycophenolate mofetil—psoriasis	0.000168	0.000305	CcSEcCtD
Anagrelide—Headache—Mycophenolate mofetil—psoriasis	0.000167	0.000303	CcSEcCtD
Anagrelide—Malaise—Methotrexate—psoriasis	0.000167	0.000303	CcSEcCtD
Anagrelide—Diarrhoea—Hydrocortisone—psoriasis	0.000166	0.000302	CcSEcCtD
Anagrelide—Urticaria—Dexamethasone—psoriasis	0.000165	0.000299	CcSEcCtD
Anagrelide—Urticaria—Betamethasone—psoriasis	0.000165	0.000299	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Prednisone—psoriasis	0.000165	0.000299	CcSEcCtD
Anagrelide—Dizziness—Prednisolone—psoriasis	0.000165	0.000299	CcSEcCtD
Anagrelide—Asthenia—Triamcinolone—psoriasis	0.000164	0.000298	CcSEcCtD
Anagrelide—Body temperature increased—Dexamethasone—psoriasis	0.000164	0.000298	CcSEcCtD
Anagrelide—Body temperature increased—Betamethasone—psoriasis	0.000164	0.000298	CcSEcCtD
Anagrelide—Abdominal pain—Betamethasone—psoriasis	0.000164	0.000298	CcSEcCtD
Anagrelide—Abdominal pain—Dexamethasone—psoriasis	0.000164	0.000298	CcSEcCtD
Anagrelide—Insomnia—Prednisone—psoriasis	0.000164	0.000297	CcSEcCtD
Anagrelide—Nausea—Cyclosporine—psoriasis	0.000163	0.000295	CcSEcCtD
Anagrelide—Paraesthesia—Prednisone—psoriasis	0.000163	0.000295	CcSEcCtD
Anagrelide—Pruritus—Triamcinolone—psoriasis	0.000162	0.000294	CcSEcCtD
Anagrelide—Cough—Methotrexate—psoriasis	0.000162	0.000293	CcSEcCtD
Anagrelide—Dizziness—Hydrocortisone—psoriasis	0.000161	0.000292	CcSEcCtD
Anagrelide—Convulsion—Methotrexate—psoriasis	0.000161	0.000291	CcSEcCtD
Anagrelide—Dyspepsia—Prednisone—psoriasis	0.000159	0.000289	CcSEcCtD
Anagrelide—Nausea—Mycophenolate mofetil—psoriasis	0.000159	0.000288	CcSEcCtD
Anagrelide—Myalgia—Methotrexate—psoriasis	0.000158	0.000286	CcSEcCtD
Anagrelide—Arthralgia—Methotrexate—psoriasis	0.000158	0.000286	CcSEcCtD
Anagrelide—Chest pain—Methotrexate—psoriasis	0.000158	0.000286	CcSEcCtD
Anagrelide—Decreased appetite—Prednisone—psoriasis	0.000157	0.000285	CcSEcCtD
Anagrelide—Rash—Prednisolone—psoriasis	0.000157	0.000285	CcSEcCtD
Anagrelide—Dermatitis—Prednisolone—psoriasis	0.000157	0.000284	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000157	0.000284	CcSEcCtD
Anagrelide—Fatigue—Prednisone—psoriasis	0.000156	0.000283	CcSEcCtD
Anagrelide—Headache—Prednisolone—psoriasis	0.000156	0.000283	CcSEcCtD
Anagrelide—Discomfort—Methotrexate—psoriasis	0.000156	0.000283	CcSEcCtD
Anagrelide—Constipation—Prednisone—psoriasis	0.000155	0.000281	CcSEcCtD
Anagrelide—Vomiting—Hydrocortisone—psoriasis	0.000155	0.00028	CcSEcCtD
Anagrelide—Rash—Hydrocortisone—psoriasis	0.000153	0.000278	CcSEcCtD
Anagrelide—Dermatitis—Hydrocortisone—psoriasis	0.000153	0.000278	CcSEcCtD
Anagrelide—Confusional state—Methotrexate—psoriasis	0.000153	0.000277	CcSEcCtD
Anagrelide—Headache—Hydrocortisone—psoriasis	0.000152	0.000276	CcSEcCtD
Anagrelide—Dizziness—Triamcinolone—psoriasis	0.000151	0.000275	CcSEcCtD
Anagrelide—Infection—Methotrexate—psoriasis	0.00015	0.000272	CcSEcCtD
Anagrelide—Feeling abnormal—Prednisone—psoriasis	0.000149	0.00027	CcSEcCtD
Anagrelide—Asthenia—Betamethasone—psoriasis	0.000149	0.00027	CcSEcCtD
Anagrelide—Asthenia—Dexamethasone—psoriasis	0.000149	0.00027	CcSEcCtD
Anagrelide—Nervous system disorder—Methotrexate—psoriasis	0.000148	0.000269	CcSEcCtD
Anagrelide—Thrombocytopenia—Methotrexate—psoriasis	0.000148	0.000269	CcSEcCtD
Anagrelide—Gastrointestinal pain—Prednisone—psoriasis	0.000148	0.000268	CcSEcCtD
Anagrelide—Nausea—Prednisolone—psoriasis	0.000148	0.000268	CcSEcCtD
Anagrelide—Pruritus—Betamethasone—psoriasis	0.000147	0.000267	CcSEcCtD
Anagrelide—Pruritus—Dexamethasone—psoriasis	0.000147	0.000267	CcSEcCtD
Anagrelide—Skin disorder—Methotrexate—psoriasis	0.000147	0.000266	CcSEcCtD
Anagrelide—Hyperhidrosis—Methotrexate—psoriasis	0.000146	0.000265	CcSEcCtD
Anagrelide—Vomiting—Triamcinolone—psoriasis	0.000146	0.000264	CcSEcCtD
Anagrelide—Nausea—Hydrocortisone—psoriasis	0.000144	0.000262	CcSEcCtD
Anagrelide—Rash—Triamcinolone—psoriasis	0.000144	0.000262	CcSEcCtD
Anagrelide—Dermatitis—Triamcinolone—psoriasis	0.000144	0.000262	CcSEcCtD
Anagrelide—Anorexia—Methotrexate—psoriasis	0.000144	0.000261	CcSEcCtD
Anagrelide—Urticaria—Prednisone—psoriasis	0.000144	0.000261	CcSEcCtD
Anagrelide—Headache—Triamcinolone—psoriasis	0.000143	0.00026	CcSEcCtD
Anagrelide—Body temperature increased—Prednisone—psoriasis	0.000143	0.000259	CcSEcCtD
Anagrelide—Abdominal pain—Prednisone—psoriasis	0.000143	0.000259	CcSEcCtD
Anagrelide—Diarrhoea—Dexamethasone—psoriasis	0.000142	0.000258	CcSEcCtD
Anagrelide—Diarrhoea—Betamethasone—psoriasis	0.000142	0.000258	CcSEcCtD
Anagrelide—Hypotension—Methotrexate—psoriasis	0.000141	0.000256	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000138	0.00025	CcSEcCtD
Anagrelide—Dizziness—Dexamethasone—psoriasis	0.000137	0.000249	CcSEcCtD
Anagrelide—Dizziness—Betamethasone—psoriasis	0.000137	0.000249	CcSEcCtD
Anagrelide—Insomnia—Methotrexate—psoriasis	0.000137	0.000248	CcSEcCtD
Anagrelide—Nausea—Triamcinolone—psoriasis	0.000136	0.000247	CcSEcCtD
Anagrelide—Paraesthesia—Methotrexate—psoriasis	0.000136	0.000246	CcSEcCtD
Anagrelide—Dyspnoea—Methotrexate—psoriasis	0.000135	0.000244	CcSEcCtD
Anagrelide—Somnolence—Methotrexate—psoriasis	0.000134	0.000244	CcSEcCtD
Anagrelide—Dyspepsia—Methotrexate—psoriasis	0.000133	0.000241	CcSEcCtD
Anagrelide—Vomiting—Betamethasone—psoriasis	0.000132	0.00024	CcSEcCtD
Anagrelide—Vomiting—Dexamethasone—psoriasis	0.000132	0.00024	CcSEcCtD
Anagrelide—Decreased appetite—Methotrexate—psoriasis	0.000131	0.000238	CcSEcCtD
Anagrelide—Rash—Betamethasone—psoriasis	0.000131	0.000238	CcSEcCtD
Anagrelide—Rash—Dexamethasone—psoriasis	0.000131	0.000238	CcSEcCtD
Anagrelide—Dermatitis—Betamethasone—psoriasis	0.000131	0.000237	CcSEcCtD
Anagrelide—Dermatitis—Dexamethasone—psoriasis	0.000131	0.000237	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Methotrexate—psoriasis	0.000131	0.000237	CcSEcCtD
Anagrelide—Fatigue—Methotrexate—psoriasis	0.00013	0.000236	CcSEcCtD
Anagrelide—Headache—Dexamethasone—psoriasis	0.00013	0.000236	CcSEcCtD
Anagrelide—Headache—Betamethasone—psoriasis	0.00013	0.000236	CcSEcCtD
Anagrelide—Asthenia—Prednisone—psoriasis	0.00013	0.000235	CcSEcCtD
Anagrelide—Pain—Methotrexate—psoriasis	0.000129	0.000235	CcSEcCtD
Anagrelide—Pruritus—Prednisone—psoriasis	0.000128	0.000232	CcSEcCtD
Anagrelide—Feeling abnormal—Methotrexate—psoriasis	0.000125	0.000226	CcSEcCtD
Anagrelide—Diarrhoea—Prednisone—psoriasis	0.000124	0.000225	CcSEcCtD
Anagrelide—Gastrointestinal pain—Methotrexate—psoriasis	0.000124	0.000224	CcSEcCtD
Anagrelide—Nausea—Dexamethasone—psoriasis	0.000123	0.000224	CcSEcCtD
Anagrelide—Nausea—Betamethasone—psoriasis	0.000123	0.000224	CcSEcCtD
Anagrelide—Urticaria—Methotrexate—psoriasis	0.00012	0.000218	CcSEcCtD
Anagrelide—Dizziness—Prednisone—psoriasis	0.00012	0.000217	CcSEcCtD
Anagrelide—Abdominal pain—Methotrexate—psoriasis	0.00012	0.000217	CcSEcCtD
Anagrelide—Body temperature increased—Methotrexate—psoriasis	0.00012	0.000217	CcSEcCtD
Anagrelide—Vomiting—Prednisone—psoriasis	0.000115	0.000209	CcSEcCtD
Anagrelide—Rash—Prednisone—psoriasis	0.000114	0.000207	CcSEcCtD
Anagrelide—Dermatitis—Prednisone—psoriasis	0.000114	0.000207	CcSEcCtD
Anagrelide—Headache—Prednisone—psoriasis	0.000113	0.000206	CcSEcCtD
Anagrelide—Asthenia—Methotrexate—psoriasis	0.000109	0.000197	CcSEcCtD
Anagrelide—Nausea—Prednisone—psoriasis	0.000108	0.000195	CcSEcCtD
Anagrelide—Pruritus—Methotrexate—psoriasis	0.000107	0.000194	CcSEcCtD
Anagrelide—Diarrhoea—Methotrexate—psoriasis	0.000103	0.000188	CcSEcCtD
Anagrelide—Dizziness—Methotrexate—psoriasis	0.0001	0.000181	CcSEcCtD
Anagrelide—Vomiting—Methotrexate—psoriasis	9.62e-05	0.000174	CcSEcCtD
Anagrelide—Rash—Methotrexate—psoriasis	9.54e-05	0.000173	CcSEcCtD
Anagrelide—Dermatitis—Methotrexate—psoriasis	9.53e-05	0.000173	CcSEcCtD
Anagrelide—Headache—Methotrexate—psoriasis	9.48e-05	0.000172	CcSEcCtD
Anagrelide—Nausea—Methotrexate—psoriasis	8.99e-05	0.000163	CcSEcCtD
